Best Healthcare ETF in India 2026

Healthcare is one of those sectors investors often describe as “defensive.”

That description is only partly correct.

People keep buying medicines and going to hospitals no matter how the economy is doing, but that doesn't mean healthcare stocks always move smoothly. Pharma companies deal with a lot, USFDA inspections, pricing pressure on generic drugs, and the risk that all the money they spend on research doesn't always pay off. Hospitals need to spend a lot of money upfront too if they want to keep growing. Diagnostics companies face competition, while valuations across successful healthcare businesses can become demanding.

Best Healthcare ETF in India

1. ICICI Prudential Nifty Healthcare ETF

ICICI Prudential Nifty Healthcare ETF tracks the Nifty Healthcare TRI, providing passive exposure to India's leading listed healthcare companies.

Strengths

• Largest AUM among the five ETFs discussed here

• Competitive expense ratio

• Established operating history

• Exposure across pharmaceuticals and healthcare services

• Backed by a large AMC

Weaknesses

• Concentrated in the same 20-stock benchmark as several competitors

• Sun Pharma carries a large individual weight

• Healthcare sector valuations can become expensive

• Does not provide broad-market diversification

2. DSP Nifty Healthcare ETF

DSP Nifty Healthcare ETF was launched in February 2024 and tracks the Nifty Healthcare TRI.

Strengths

• Very low reported tracking error

• Straightforward Nifty Healthcare exposure

• Competitive base expense ratio

• Transparent portfolio disclosure

Weaknesses

• Relatively small AUM

• Total expense ratio is higher than the base ratio

• Exchange liquidity may be lower than larger ETFs

• Same concentration as other Nifty Healthcare trackers

3. Aditya Birla Sun Life Nifty Healthcare ETF

Aditya Birla Sun Life Nifty Healthcare ETF has been operating since October 2021 and also tracks the Nifty Healthcare TRI.

Strengths

• Very low reported tracking error

• Competitive expense ratio

• Longer operating history than several newer peers

• Reasonable AUM

• Simple passive structure

Weaknesses

• Less AUM than ICICI Prudential

• Sector remains highly concentrated

• Portfolio is essentially similar to other Nifty Healthcare ETFs

• Trading liquidity needs to be checked separately from AUM

4. Axis Nifty Healthcare ETF

Axis Nifty Healthcare ETF has operated since May 2021 and tracks the Nifty Healthcare TRI.

Strengths

• More than five years of operating history

• Very low current tracking error

• Established AMC

• Clear benchmark exposure

• Historical performance closely follows the index

Weaknesses

• Higher expense ratio than several competing ETFs

• Relatively small AUM

• Same underlying portfolio as cheaper Nifty Healthcare ETFs

• Sector concentration remains high

5. Mirae Asset Nifty 500 Healthcare ETF

Mirae Asset Nifty 500 Healthcare ETF is the most structurally different fund on this list.

It launched in February 2026 and tracks the Nifty 500 Healthcare TRI, rather than the narrower Nifty Healthcare Index.

Strengths

• Broader healthcare benchmark

• Potential exposure to more healthcare companies

• Better opportunity to capture mid-sized healthcare businesses

• Less dependent on only the largest 20 names

• Diversification across the broader Nifty 500 healthcare universe

Weaknesses

• Very short operating history

• Small AUM

• Liquidity needs close monitoring

• Wider benchmark can introduce more mid/small-cap volatility

• Limited long-term tracking history

Factors to Consider Before Investing in Healthcare ETFs

1. Financial Health

An ETF diversifies company-specific risk, but the businesses underneath still need to perform.

For pharmaceutical companies, I monitor:

• Revenue growth

• R&D spending

• Operating margins

• US business performance

• New-product launches

• Regulatory compliance

For hospitals:

• Occupancy

• Average revenue per occupied bed

• Bed additions

• EBITDA margins

• Return on new hospital capex

2. Government Policies

Healthcare is heavily regulated.

Drug-pricing rules, hospital regulations, government insurance programmes, taxation, clinical requirements and pharmaceutical manufacturing standards can all affect profitability.

Policy can simultaneously expand healthcare access and put pressure on industry margins.

3. Global Competition

Indian pharma companies don't just compete at home, they compete globally too. Things like generic drug pricing in the US, regulatory inspections, currency movements, and competition from manufacturers in other countries can all have a real impact on their earnings.

That's why a healthcare ETF in India isn't purely a bet on domestic demand.

4. Sustainability

Healthcare has an obvious social role, but investors still need to analyse sustainable business economics.

Hospitals need disciplined expansion.

Pharmaceutical companies need continuous R&D.

Manufacturers also need strong quality-control and regulatory systems.

Growth that relies on excessive capex or weak compliance is rarely sustainable.

Conclusion

A healthcare ETF can be a useful way to participate in India's pharmaceutical, hospital and broader healthcare growth story without choosing individual companies.

Among the standard Nifty Healthcare trackers, ICICI Prudential currently stands out for scale, while Aditya Birla Sun Life and DSP show competitive tracking and cost characteristics. Axis offers a longer history but currently carries a relatively higher expense ratio.

Mirae Asset Nifty 500 Healthcare ETF is different: its broader benchmark can provide exposure to up to 50 healthcare companies, but the fund is still new and relatively small.